07/19/2019
10:52 AM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) |  |
07/15/2019
3:00 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2019
8:37 AM | Insys Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE
| |
06/10/2019
7:00 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
6:18 AM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
1:08 PM | Insys Therapeutics (Filer)
| Form 8-K/A
| |
06/06/2019
4:11 PM | Housley Andrece (Reporting)
Insys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2019
4:09 PM | Housley Andrece (Reporting)
Insys Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2019
8:42 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2019
4:31 PM | Insys Therapeutics (Issuer)
Long Andrew G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2019
4:18 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
8:44 PM | Insys Therapeutics (Filer)
| Form NT 10-Q
| |
05/10/2019
8:04 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
3:14 PM | Insys Therapeutics (Filer)
| Form 10-K/A
| |
04/29/2019
11:36 AM | ETF MANAGERS GROUP, LLC (Filed by)
Insys Therapeutics (Subject)
| Form SC 13G/A
| |
04/23/2019
6:16 PM | BOHLEN ELIZABETH (Reporting)
Insys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
6:15 PM | Insys Therapeutics (Issuer)
Mahboob Vaseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
6:15 PM | Insys Therapeutics (Issuer)
Nance Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
6:14 PM | Insys Therapeutics (Issuer)
Vanhove Geertrui (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
6:13 PM | Insys Therapeutics (Issuer)
Vanhove Geertrui (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/23/2019
6:12 PM | Insys Therapeutics (Issuer)
Motahari Saeed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
6:11 PM | Insys Therapeutics (Issuer)
Long Andrew G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
6:10 PM | Insys Therapeutics (Issuer)
MEYER STEVEN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
6:09 PM | Insys Therapeutics (Issuer)
LAPALME PIERRE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
6:07 PM | Insys Therapeutics (Issuer)
Vishnoi Rohit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2019
4:21 PM | Insys Therapeutics (Filer)
| Form 8-K/A
| |
04/23/2019
4:18 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2019
8:46 PM | Insys Therapeutics (Issuer)
Vishnoi Rohit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:41 PM | Insys Therapeutics (Issuer)
Long Andrew G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:40 PM | Insys Therapeutics (Issuer)
Motahari Saeed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:38 PM | Insys Therapeutics (Issuer)
Nance Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:35 PM | Insys Therapeutics (Issuer)
Mahboob Vaseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:34 PM | BOHLEN ELIZABETH (Reporting)
Insys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:32 PM | Insys Therapeutics (Issuer)
LAPALME PIERRE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:31 PM | Insys Therapeutics (Issuer)
MEYER STEVEN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:30 PM | Insys Therapeutics (Issuer)
Vanhove Geertrui (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2019
8:28 PM | Insys Therapeutics (Issuer)
Vanhove Geertrui (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/18/2019
4:20 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2019
8:52 PM | Insys Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2019
3:13 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2019
10:24 AM | ETF MANAGERS GROUP, LLC (Filed by)
Insys Therapeutics (Subject)
| Form SC 13G/A
| |
02/26/2019
12:22 PM | ETF MANAGERS GROUP, LLC (Filed by)
Insys Therapeutics (Subject)
| Form SC 13G/A
| |
02/19/2019
1:05 PM | ETF MANAGERS GROUP, LLC (Filed by)
Insys Therapeutics (Subject)
| Form SC 13G
| |
11/09/2018
12:45 PM | Insys Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2018
3:51 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2018
3:43 PM | Insys Therapeutics (Issuer)
Nance Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2018
3:42 PM | Insys Therapeutics (Issuer)
Nance Mark E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/09/2018
3:13 PM | BOHLEN ELIZABETH (Reporting)
Insys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2018
1:48 PM | Insys Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2018
4:24 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2018
2:10 PM | Insys Therapeutics (Issuer)
Long Andrew G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
4:50 PM | Insys Therapeutics (Issuer)
Tambi Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2018
4:03 PM | Insys Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2018
1:55 PM | Insys Therapeutics (Issuer)
Vishnoi Rohit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2018
1:54 PM | Insys Therapeutics (Issuer)
LAPALME PIERRE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2018
1:53 PM | Insys Therapeutics (Issuer)
MEYER STEVEN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2018
1:27 PM | Insys Therapeutics (Issuer)
Motahari Saeed (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2018
3:27 PM | Insys Therapeutics (Filer)
| Form DEF 14A
| |
04/02/2018
12:27 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2018
5:24 PM | Insys Therapeutics (Issuer)
Insys Therapeutics, Inc. Voting Trust (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/08/2018
4:29 PM | Insys Therapeutics (Subject)
Insys Therapeutics, Inc. Voting Trust (Filed by)
| Form SC 13D
| |
03/01/2018
5:00 PM | Insys Therapeutics (Issuer)
JOHN N KAPOOR TRUST DATED SEPTEMBER 20 1989 (Reporting)
KAPOOR JOHN N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2018
7:40 AM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2018
1:45 PM | Insys Therapeutics (Issuer)
Mahboob Vaseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2018
1:44 PM | Insys Therapeutics (Issuer)
Mahboob Vaseem (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/16/2018
3:47 PM | Insys Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2018
3:42 PM | Insys Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A
| |
02/01/2018
2:05 PM | Insys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2017
12:59 PM | Insys Therapeutics (Filer)
| Form CT ORDER
| |
